Athersys and University Hospitals Cleveland Medical Center announce activation of first clinical site for MACOVIA study for COVID-19 Induced ARDS
On May 1, 2020, Athersys and University Hospitals Cleveland Medical Center (UH Cleveland) announced that UH Cleveland is now open as the first clinical site for the MACOVIA (MultiStemﾮAdministration for COVID-19 Induced Acute Respiratory Distress Syndrome) trial.
Tags:
Source: Athersys
Credit:
